Search

Search Results for "AMD/DME"

AMD/DME Case Files: Real-World Patient Profiles

Retina specialists share challenging real-world cases of wet AMD and DME.

Exploring Treatment Strategies for Wet AMD and DME

Data Update: Faricimab for AMD & DME thumbnail

Data Update: Faricimab for AMD & DME

Carl D. Regillo, MD

story 1 thumbnail

Trials Examine Use of High-Dose Aflibercept for 12- and 16-Week Dosing for Wet AMD and DME

High-Dose Aflibercept in the Real World thumbnail

High-Dose Aflibercept in the Real World

Diana Do, MD

Wet AMD and DME Therapy in Development thumbnail

Wet AMD and DME Therapy in Development

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

Contemporary Discussions in Medical Retina Therapy: The Realities of Patient Compliance, Treatment Burden, and Disease Response in Wet AMD and DME thumbnail

Contemporary Discussions in Medical Retina Therapy: The Realities of Patient Compliance, Treatment Burden, and Disease Response in Wet AMD and DME

Margaret A. Chang, MD, MS; Patricia Udaondo, MD

Next-Gen Therapies for AMD and DME thumbnail

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

Goals and Challenges in Treating Wet AMD and DME thumbnail

Goals and Challenges in Treating Wet AMD and DME

Diana V. Do, MD; David S. Chin Yee, MD; Esther L. Kim, MD; Charles C. Wykoff, MD, PhD

Roundtable: Balancing Safety Concerns With Unmet Needs in Wet AMD and DME Therapy thumbnail

Roundtable: Balancing Safety Concerns With Unmet Needs in Wet AMD and DME Therapy

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

What Evidence Makes EYP-1901 a Promising Treatment for Wet AMD and DME? thumbnail

What Evidence Makes EYP-1901 a Promising Treatment for Wet AMD and DME?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

A Treatment Paradigm for Wet AMD thumbnail

A Treatment Paradigm for Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 2/3 Clinical Trial Data for EYLEA HD<sup>®</sup> (aflibercept) Injection 8 mg for the Treatment of DME thumbnail

Phase 2/3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of DME

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet
AMD thumbnail

Phase 3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Treatment Durability thumbnail

Treatment Durability

Diana V. Do, MD; David S. Chin Yee, MD; Esther L. Kim, MD; Charles C. Wykoff, MD, PhD

View More